人工器官市场规模、份额、成长分析（按器官类型、固定方法、最终用户和地区）—2025 年至 2032 年产业预测

2023 年全球人工器官市场规模为 285 亿美元，预计将从 2024 年的 307.5 亿美元成长到 2032 年的 565 亿美元，预测期间（2025-2032 年）的复合年增长率为 7.9%。

全球老化显着提升了器官移植的重要性，尤其对于65岁以上的人而言，他们既是器官移植的接受者，也是器官移植的寻求者。随着这一人群的成长，由于移植后併发症风险的增加，对假体的需求也随之增加。患者数量的增长表明，随着越来越多的患者需要接受移植手术，等待移植的名单可能会越来越长。 OPTN现代化计划等创新旨在提高器官移植的系统效率和数据透明度。此外，3D生物列印等技术进步正获得支持，用于製造排斥风险较低的人造器官。人工智慧与器官捐赠者相容性评估的整合，代表着復原和病人接受度决策流程迈出了变革性的一步。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 专利分析

人工器官市场规模（依器官类型及复合年增长率）(2025-2032)

• 市场概览
• 人工肾
• 人工肝
• 人工肺
• 人工胰臟
• 人工心臟
• 其他器官类型

人造器官市场规模（依固定方法和复合年增长率） (2025-2032)

• 市场概览
• 嵌入式
• 穿戴式装置

人工器官市场规模（依最终用户和复合年增长率）(2025-2032)

• 市场概览
• 医院
• 学术研究所
• 其他的

人造器官市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Berlin Heart
• Abbott
• Boston Scientific
• Cochlear
• Edwards Lifesciences
• Ekso Bionics
• Jarvik Heart
• Medtronic
• SynCardia Systems
• Zimmer Biomet
• Wearable Artificial Organs, Inc
• CARMAT
• BiVACOR Inc.
• TransMedics
• Fresenius Medical Care

结论和建议

Global Artificial Organs Market size was valued at USD 28.5 billion in 2023 and is poised to grow from USD 30.75 billion in 2024 to USD 56.5 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The global aging population is significantly increasing the importance of organ transplantation, particularly among individuals over 65 who are both recipients and seekers of transplants. As this demographic grows, so does the demand for prosthetic devices, driven by their heightened risk of post-implantation complications. The growing numbers indicate a potential increase in transplant waiting lists as more patients require procedures. Innovations such as the OPTN Modernization Initiative aim to enhance system efficiency and data transparency in organ transplantation. Additionally, advancements like 3D bioprinting are gaining traction for creating artificial organs with a lower risk of rejection. The integration of artificial intelligence in assessing organ and donor compatibility represents a transformative step in decision-making processes for both recovery and patient acceptance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Organs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Organs Market Segments Analysis

Global Artificial Organs Market is segmented by Organ Type, Fixation, End-User and region. Based on Organ Type, the market is segmented into Artificial kidney, Artificial liver, Artificial lungs, Artificial pancreas, Artificial heart and Other organ types. Based on Fixation, the market is segmented into Implantable and Wearable. Based on End-User, the market is segmented into Hospitals, Academic and Research Institutes and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Organs Market

The Global Artificial Organs market is significantly driven by the rising prevalence of chronic illnesses like kidney failure, heart disease, and liver disease. As more patients experience organ dysfunction, the need for prosthetic organs, including dialysis machines, artificial hearts, and liver support systems, is rapidly increasing. This escalating demand is further accentuated by an aging population and deteriorating quality of life, contributing to an urgent need for life-saving medical interventions. Consequently, the surge in chronic disease cases is propelling the growth of the artificial organs market, highlighting the critical role these technologies play in improving patient outcomes and enhancing overall quality of care.

Restraints in the Global Artificial Organs Market

Although there have been significant advancements in technology, the exorbitant costs associated with prosthetics and related medical procedures continue to hinder the growth of the global artificial organs market. The extensive expenses incurred during the research, development, and manufacturing phases of these devices often render them unaffordable for a large segment of the global population, particularly in developing regions. Consequently, individuals with lower income levels or inadequate access to healthcare services face considerable barriers in obtaining prosthetic solutions. This financial constraint significantly restricts the reach and effectiveness of artificial organs, limiting their availability to those who need them the most.

Market Trends of the Global Artificial Organs Market

The Global Artificial Organs market is witnessing a significant trend driven by the integration of 3D printing technology in prosthetics. This innovation allows for the creation of customized, patient-specific organs that enhance accuracy, functionality, and biocompatibility, addressing individual healthcare needs more effectively. The ability to rapidly produce high-quality prosthetics at lower costs not only increases accessibility but also accelerates the manufacturing process, making 3D printing a pivotal segment within the market. As a result, stakeholders are increasingly investing in this technology, anticipating its role in reshaping healthcare solutions and improving the quality of life for patients worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Artificial Organs Market Size by Organ Type & CAGR (2025-2032)

• Market Overview
• Artificial kidney
• Artificial liver
• Artificial lungs
• Artificial pancreas
• Artificial heart
• Other organ types

Global Artificial Organs Market Size by Fixation & CAGR (2025-2032)

• Market Overview
• Implantable
• Wearable

Global Artificial Organs Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Academic and Research Institutes
• Others

Global Artificial Organs Market Size & CAGR (2025-2032)

• North America (Organ Type, Fixation, End-User)
  • US
  • Canada
• Europe (Organ Type, Fixation, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Organ Type, Fixation, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Organ Type, Fixation, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Organ Type, Fixation, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Berlin Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ekso Bionics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wearable Artificial Organs, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARMAT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransMedics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations